Effectiveness of implantable cardioverter defibrillators for primary prevention of sudden cardiac death in subgroups: A systematic review

Annals of Internal Medicine

Volumn 160, Issue 2, 2014, Pages 111-121

  Earley, Amy ^a   Persson, Rebecca ^a   Garlitski, Ann C ^a   Balk, Ethan M ^a   Uhlig, Katrin ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; DIABETES MELLITUS; FALSE NEGATIVE RESULT; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICARE; META ANALYSIS; NEW YORK HEART ASSOCIATION CLASS; PRIMARY PREVENTION; PRIORITY JOURNAL; QRS COMPLEX; QUALITY CONTROL; SEX DIFFERENCE; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; UREA NITROGEN BLOOD LEVEL;

AGE FACTORS; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PRIMARY PREVENTION; RISK FACTORS; SEX FACTORS;

EID: 84893232684     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-1787     Document Type: Article

References (47)

1. Uhlig K, Balk EM, Earley A, Persson R, Garlitski AC, Chen M, et al. Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death. AHRQ Health Technology Assessments. 2013. Accessed at www.cms.gov/Medicare/Coverage/DeterminationProcess/Downloads/id91TA.pdf on 2 December 2013.
2. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/ AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350-408. [PMID: 18483207]
3. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol. 2002;40:1703-19. [PMID: 12427427]
4. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol. 2004;44:2166-72. [PMID: 15582314]
5. Santangeli P, Di Biase L, Dello Russo A, Casella M, Bartoletti S, Santarelli P, et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter defibrillators. Ann Intern Med. 2010;153:592-9. [PMID: 21041579]
6. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, et al. Effectiveness of implantable cardioverter defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169:1500-6. [PMID: 19752408]
7. Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, et al. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm. 2010;7:876-82. [PMID: 20380893]
8. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37. [PMID: 15659722]
9. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337:1569-75. [PMID: 9371853]
10. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50. [PMID: 15152059]
11. Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes. 2009;2:16-24. [PMID: 20031808]
12. Hernandez AF, Fonarow GC, Hammill BG, Al-Khatib SM, Yancy CW, O'Connor CM, et al. Clinical effectiveness of implantable cardioverter defibrillators among Medicare beneficiaries with heart failure. Circ Heart Fail. 2010;3:7-13. [PMID: 20009044]
13. Hoffmeister JM, Estes NA 3rd, Garlitski AC. Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator. J Interv Card Electrophysiol. 2012;35:227-34. [PMID: 22956011]
14. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al; DINAMIT Investigators. Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-8. [PMID: 15590950]
15. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-8. [PMID: 15152060]
16. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933-40. [PMID: 8960472]
17. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83. [PMID: 11907286]
18. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, et al; IRIS Investigators. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427-36. [PMID: 19812399]
19. Wallace BC, Trikalinos TA, Lau J, Brodley C, Schmid CH. Semiautomated screening of biomedical citations for systematic reviews. BMC Bioinformatics. 2010;11:55. [PMID: 20102628]
20. Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess. 2001;5:1-56. [PMID: 11701102]
21. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357:2189-94. [PMID: 18032770]
22. Brockwell SE, Gordon IR. A comparison of statistical methods for metaanalysis. Stat Med. 2001;20:825-40. [PMID: 11252006]
23. Al-Khatib SM, Hellkamp AS, Lee KL, Anderson J, Poole JE, Mark DB, et al; SCD-HeFT investigators. Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). J Cardiovasc Electrophysiol. 2008;19:1059-65. [PMID: 18479330]
24. Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial-II Investigators. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol. 2006;98:485-90. [PMID: 16893702]
25. Goldenberg I, Moss AJ. Treatment of arrhythmias and use of implantable cardioverter defibrillators to improve survival in elderly patients with cardiac disease. Clin Geriatr Med. 2007;23:205-19. [PMID: 17126763]
26. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, et al; MADIT-II Research Group. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007;18:833-8. [PMID: 17537209]
27. Mitchell JE, Hellkamp AS, Mark DB, Anderson J, Poole JE, Lee KL, et al; SCD-HeFT Investigators. Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J. 2008;155:501-6. [PMID: 18294487]
28. Piccini JP, Al-Khatib SM, Hellkamp AS, Anstrom KJ, Poole JE, Mark DB, et al. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm. 2011;8:393-400. [PMID: 21109025]
29. Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, et al. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol. 2008;19:720-4. [PMID: 18373605]
30. Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, Andrews ML, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation. 2004;109:1082-4. [PMID: 14993128]
31. Zareba W, Piotrowicz K, McNitt S, Moss AJ; MADIT II Investigators. Implantable cardioverter defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population). Am J Cardiol. 2005;95:1487-91. [PMID: 15950580]
32. Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation. 2002;105:1453-8. [PMID: 11914254]
33. Barsheshet A, Moss AJ, McNitt S, Jons C, Glikson M, Klein HU, et al; MADIT-II Executive Committee. Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter defibrillator. Heart Rhythm. 2011;8:212-8. [PMID: 21044897]
34. Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, et al. Differences in outcomes between patients treated with single-versus dualchamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II. Ann Noninvasive Electrocardiol. 2005;10:429-35. [PMID: 16255753]
35. Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, et al; MADIT-II Investigators. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006;47:1811-7. [PMID: 16682305]
36. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Qualityof-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol. 1999;22:1305-13. [PMID: 10527011]
37. Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, et al; Multicenter Automatic Defibrillator Implantation Trial II. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care. 2007;45:377-85. [PMID: 17446823]
38. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al; AMIOVIRT Investigators. Amiodarone versus implantable cardioverter defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia- AMIOVIRT. J Am Coll Cardiol. 2003;41:1707-12. [PMID: 12767651]
39. Fonarow GC, Feliciano Z, Boyle NG, Knight L, Woo MA, Moriguchi JD, et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter defibrillator. Am J Cardiol. 2000;85:981-5. [PMID: 10760339]
40. Mezu U, Adelstein E, Jain S, Saba S. Effectiveness of implantable defibrillators in octogenarians and nonagenarians for primary prevention of sudden cardiac death. Am J Cardiol. 2011;108:718-22. [PMID: 21640321]
41. Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, et al. Survival of patients receiving a primary prevention implantable cardioverter defibrillator in clinical practice vs. clinical trials. JAMA. 2013;309:55-62. [PMID: 23280225]
42. Santangeli P, Di Biase L, Dello RA, Casella M, Bartoletti S, Santarelli P, et al. Age and effectiveness of prophylactic implantable cardioverter defibrillators [Erratum]. Ann Intern Med. 2011;154:780.
43. Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010; 340:c117. [PMID: 20354011]
44. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000;342:1937-45. [PMID: 10874061]
45. Masoudi FA, Go AS, Magid DJ, Cassidy-Bushrow AE, Doris JM, Fiocchi F, et al. Longitudinal study of implantable cardioverter defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes. 2012;5:e78-85. [PMID: 23170006]
46. Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA; National Cardiovascular Data's ICD Registry. Influence of age on perioperative complications among patients undergoing implantable cardioverter defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes. 2011;4:549-56. [PMID: 21878667]
47. Chen CY, Stevenson LW, Stewart GC, Seeger JD, Williams L, Jalbert JJ, et al. Impact of baseline heart failure burden on post-implantable cardioverter defibrillator mortality among Medicare beneficiaries. J Am Coll Cardiol. 2013;61:2142-50. [PMID: 23541973]